JOHNSON CITY, Tenn.,
April 13, 2016 /PRNewswire/
-- NN, Inc., (NASDAQ: NNBR), a diversified industrial company,
announced today that it will attend the BIOMEDevice Conference and
Expo in Boston, MA on April
13th-14th, 2016.
The BIOMEDevice Conference and Expo brings together industry
thought leaders to discuss the latest medical technologies,
advanced manufacturing techniques, new materials, and suppliers
from every step in the medical manufacturing process.
NN will be displaying its comprehensive product and process
platform that delivers engineered solutions for several end-markets
including the medical device industry. Visitors to the NN display,
booth 305, will be able to see all of our product capabilities:
molded and machined plastics, progressive metal stamping, precision
machining, and additive manufacturing. In addition visitors will be
able to speak with our technical team about precision components
and assemblies that utilize our global technology platform.
Chris Qualters, Vice President
and Chief Commercial Officer,
commented, "Our engineered solution platform allows us to
collaborate with our customers on designs and manufacturing
technologies that result in more capable products to improve
patient outcomes." Qualters continued, "We are looking forward to
BIOMEDevice as it provides an opportunity for us to work together
with new and established partners, fellow engineers, designers, and
managers to bring the next big thing in the medical device industry
into reality."
NN, Inc., a diversified industrial company, combines advanced
engineering and production capabilities with in-depth materials
science expertise to design and manufacture high-precision
components and assemblies for a variety of markets on a global
basis. Headquartered in Johnson
City, Tennessee, NN has 42 manufacturing plants in
North America, Western Europe, Eastern Europe, South America and China.
Except for specific historical information, many of the
matters discussed in this press release may express or imply
projections of revenues or expenditures, statements of plans and
objectives or future operations or statements of future economic
performance. These, and similar statements, are forward-looking
statements concerning matters that involve risks, uncertainties and
other factors which may cause the actual performance of NN, Inc.
and its subsidiaries to differ materially from those expressed or
implied by this discussion. All forward-looking information is
provided by the Company pursuant to the safe harbor established
under the Private Securities Litigation Reform Act of 1995 and
should be evaluated in the context of these factors.
Forward-looking statements generally can be identified by the use
of forward-looking terminology such as "assumptions", "target",
"guidance", "outlook", "plans", "projection", "may", "will",
"would", "expect", "intend", "estimate", "anticipate", "believe",
"potential" or "continue" (or the negative or other derivatives of
each of these terms) or similar terminology. Factors which could
materially affect actual results include, but are not limited to:
general economic conditions and economic conditions in the
industrial sector, inventory levels, regulatory compliance costs
and the Company's ability to manage these costs, start-up costs for
new operations, debt reduction, competitive influences, risks that
current customers will commence or increase captive production,
risks of capacity underutilization, quality issues, availability
and price of raw materials, currency and other risks associated
with international trade, the Company's dependence on certain major
customers, and the successful implementation of the global growth
plan including development of new products. Similarly, statements
made herein and elsewhere regarding completed acquisitions are also
forward-looking statements, including statements relating to the
future performance and prospects of an acquired business, the
expected benefits of an acquisition on the Company's future
business and operations and the ability of the Company to
successfully integrate recently acquired businesses.
For additional information concerning such risk factors and
cautionary statements, please see the section titled "Risk Factors"
in the Company's periodic reports filed with the Securities and
Exchange Commission, including, but not limited to, the Company's
Annual Report on Form 10-K for the fiscal year ended December 31, 2015. Except as required by law, we
undertake no obligation to update or revise any forward-looking
statements we make in our press releases, whether as a result of
new information, future events or otherwise.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nn-to-attend-biomedevice-conference--expo-300250817.html
SOURCE NN, Inc.